24小时热门版块排行榜    

查看: 543  |  回复: 3

wangyubobby

捐助贵宾 (小有名气)

[交流] 【交流】从发表论文水平看算什么水平。。新手求助 已有2人参与

Books/Book Chapters

1. Xu, Wenfang; Zhao, Guisen; Zhang, Shijun. “The Principles and Methods of New Drug Design” 1st Edition, China Medical Science and Technology Publishing House, Jul. 1997 2. Xu, Wenfang; Zhao, Guisen; Zhang, Shijun. “The Principles and Methods of New Drug Design” 2d Edition, Science Publishing House, Oct. 2000
Recent Publications

Lenhart, J.A.; Ling, X.; Gandhi, R.; Guo, T.L.; Gerk, P.M.; Brunzell, D.H.; Zhang, S. "Clicked" Bivalent Ligands Containing Curcumin and Cholesterol As Multifunctional Abeta Oligomerization Inhibitors: Design, Synthesis, and Biological Characterization. J. Med. Chem. 2010, 53, 6198-6209.
Li, Q.; Wu, J.; Zheng, H.; Liu, K.; Guo, T.L.; Liu, Y.; Eblen, S.T.; Grant, S.; Zhang, Shijun. Discovery of 3-(2-aminoethyl)-5-(3-phenyl-propylidene)-thiazolidine-2,4-dione as a dual inhibitor of the Raf/MEK/ERK and the PI3K/Akt signaling pathways. Bioorg. & Med. Chem. Lett. 2010, 20, 4526-4530.
Zhang, Shijun; Yekkirala, Ajay; Tang, Ye; Portoghese, Philip S. A bivalent ligand (KMN-21) antagonist for µ/? heterodimeric opioid receptors. Bioorg & Med. Chem. Lett. 2009, 19, 6978-6980.
Li, Qianbin; Al-Ayoubi, Adnan; Guo, Tailiang; Zheng, Hui; Sarkar, Aurijit; Nguyen, Tri; Eblen, Scott T.; Grant, Steven; Kellogg, Glen E.; Zhang, Shijun. Structure-activity relationship (SAR) studies of 3-(2- amino-ethyl)-5-(4-ethoxy-benzylidene)-thiazolidine-2,4-dione: Development of potential substrate-specific ERK1/2 inhibitors. Bioorg & Med. Chem. Lett. 2009, 19, 6042-6046.
Zhang, Shijun; Fernandez, Fernando; Zhen, Juan; Reith, Maarten E. A.; Dutta, Aloke K.. Further structural exploration of tri-substituted asymmetric pyran derivaives, (2S, 4R, 5R)-2-benzhydryl-5- benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S, 6S)-pyran derivatives: A proposed pharmacohpore model for high affinity interaction with the dopamine, serotonin, and norepinephrine transporters. J. Med. Chem. 2006, 49, 4239-4237.
Zhang, Shijun; Zhen, Juan; Reith, Maarten E. A.; Dutta, Aloke K.. Design, Synthesis, and Preliminary SAR Study of 3-and 6-Sides-Chain Extended Tetrahydro-Pyran Analogues of cis- and trans-(6- benzhydryl-piperidin-3-yl)-benzylamine. Bioorg. & Med. Chem. 2006, 14, 3953- 3966.
Zhang, Shijun; Zhen, Juan; Reith, Maarten E.A.; Dutta, Aloke K.. Discovery of novel tri-substituted asymmetric pyran derivatives, (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydro-pyran-4-ol, exhibiting high affinity for serotonin and norepinephrine transporters in a stereospecific manner. J. Med. Chem. 2005, 48, 4962-4971.
Zhang, Shijun; Zhen, Juan; Reith, Maarten E.A.; Dutta, Aloke K.. Structural requirements for 2,4- and 3,6-disubstituted pyran biomimetics of cis-(6-benzhydryl-piperidin-3-yl)-benzylamine compounds to interact with monoamine transporters. Bioorg. & Med. Chem. 2004, 12, 6301- 6315.
Dutta, Aloke K.; Venkataraman, Sylesh K.; Fei, Xiang-shu; Kolhatkar, Rohit; Zhang, Shijun; Reith,Maarten E.A.. Synthesis and biological characterization of novel hybrid 7-{[2-(4-phenylpiperazin- 1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-2-ol analogues for the dopamine D2 and D3 receptors. Bioorg. & Med. Chem. 2004, 12, 4361- 4373.
Dutta, Aloke K.; Zhang, Shijun; Kohhatkar, Rohit; Reith, Maarten E.A.. Dopamine Transporter as Target for Drug Development of Cocaine Dependence Medications. Europ. J. Pharmacol. 2003, 479, 93-106.
Zhang, Shijun; Reith, Maarten E.A.; Dutta, Aloke K.. Design, synthesis, and activity of novel cis- and trans-3,6-disubstituted pyran biomimetics of 3,6-disubstituted piperidine as potential ligands for the dopamine transporter. Bioorg. & Med. Chem. Lett. 2003, 13, 1591-1595.
回复此楼
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

jiangchunyong

荣誉版主 (文坛精英)


小木虫(金币+0.5):给个红包,谢谢回帖交流
主要是BMC和JMC 在药化方面一般吧
2楼2011-03-27 21:41:06
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

wangyubobby

捐助贵宾 (小有名气)

引用回帖:
Originally posted by jiangchunyong at 2011-03-27 21:41:06:
主要是BMC和JMC 在药化方面一般吧

---水平一般啊。。。他是Virginia Commonwealth University
Department of Medicinal Chemistry    不是主攻药化吗
3楼2011-03-27 21:45:31
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

jiangchunyong

荣誉版主 (文坛精英)


小木虫(金币+0.5):给个红包,谢谢回帖交流
是药化的呀 就是一般啊
4楼2011-03-27 21:48:13
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
相关版块跳转 我要订阅楼主 wangyubobby 的主题更新
普通表情 高级回复 (可上传附件)
最具人气热帖推荐 [查看全部] 作者 回/看 最后发表
[考博] 澳大利亚 Murdoch University 全奖博士招生(3个名额)地质化工冶金领域 +25 AI8RaGaPaSCR 2026-08-07 26/1300 2026-08-13 20:15 by YSLfXhguwSL6
[硕博家园] 一作与独作在应聘高校教师时区别大吗 +3 mbygzh 2026-08-08 4/200 2026-08-13 19:31 by 龙-樱
[基金申请] 咱们一起用铁证分析2026国家社科基金中标与否 +3 启萌科技 2026-08-12 9/450 2026-08-13 19:29 by 启萌科技
[基金申请] 静等基金结果 +8 gjjjzhong 2026-08-10 21/1050 2026-08-13 17:56 by 且听虎啸
[基金申请] 有时候,自然基金真的不能太认真 (我的申报经验) +4 majunge000 2026-08-11 6/300 2026-08-13 16:50 by 四季常青藤
[基金申请] filecode +14 documentary 2026-08-10 16/800 2026-08-13 16:39 by 润生71
[基金申请] 重要来源:本周末出结果 +10 瞬息宇宙 2026-08-12 10/500 2026-08-13 15:46 by likettle
[基金申请] 分享一下我之前已中青C的计划书的filecode +4 布布和一二 2026-08-11 5/250 2026-08-13 12:56 by cratir
[基金申请] 关于Filecode分析方法 +9 majunge000 2026-08-10 11/550 2026-08-13 10:40 by ZH远山
[基金申请] 结合人工智能,周易传统文化,filecode打分制来了,3分以上希望很大。 +3 Tide man 2026-08-12 4/200 2026-08-13 08:35 by ZJTJZ
[基金申请] 应该是93bebmhtak前后十一个字符比较关键 +22 Lanmanbaby 2026-08-09 36/1800 2026-08-12 22:50 by sdfapple719
[基金申请] 好奇怪的filecode +5 布布和一二 2026-08-08 6/300 2026-08-12 16:11 by 云上清扬
[基金申请] 奇怪,两个人的filecode固定段从头到尾一模一样 +7 布布和一二 2026-08-10 10/500 2026-08-12 09:12 by 布布和一二
[基金申请] 是这周出结果还是下周出结果? +3 yuleib84 2026-08-11 3/150 2026-08-11 21:53 by jnhyjjm
[基金申请] 小木虫上这么多卖论文的,真有人买论文么?感觉没必要啊 +8 Tide man 2026-08-10 9/450 2026-08-11 20:39 by beefly
[基金申请] 为什么网上很多人说本周 12号出结果 +6 瞬息宇宙 2026-08-10 7/350 2026-08-11 19:25 by Tide man
[基金申请] 什么时候出结果,有咨询渠道??? +3 Tide man 2026-08-11 3/150 2026-08-11 17:54 by kudofaye
[基金申请] 国自然结果 +4 Vierhys 2026-08-10 8/400 2026-08-10 15:06 by Vierhys
[基金申请] 面上项目filecode邪修 +5 西山十月 2026-08-09 7/350 2026-08-10 07:32 by 仁砚薪传
[基金申请] filecode与中标关系的预测 +5 布布和一二 2026-08-07 5/250 2026-08-09 16:15 by 袁向阳007
信息提示
请填处理意见